000 | 01500cam a2200337 a 4500 | ||
---|---|---|---|
001 | 159324 | ||
005 | 20160428135749.0 | ||
008 | 980225s1998 enka 101 0 eng d | ||
010 | _a 98139493 | ||
020 |
_a0792387295 : _c£50.00 |
||
035 | _a(OCoLC)38550070 | ||
040 |
_aUk _cUk _dMoU _dDLC |
||
042 | _alccopycat | ||
050 | 0 | 0 |
_aRM405.5 _b.S45 1998 |
082 | 0 | 0 |
_a615.7 _221 |
245 | 0 | 0 |
_aSelective COX-2 inhibitors : _bpharmacology, clinical effects, and therapeutic potential : proceedings of a conference held on March 20-21, 1997, in Cannes, France / _cedited by Sir John Vane and Jack Botting. |
260 |
_aDordrecht ; _aLondon : _bKluwer Academic, _cc1998. |
||
300 |
_aix, 150 p. : _bill. ; _c24 cm. |
||
500 | _aThe conference was supported by an educational grant from Boehringer Ingelheim. | ||
500 | _aIncludes index. | ||
650 | 0 |
_aCyclooxygenases _xInhibitors _vCongresses. _954311 |
|
650 | 0 |
_aNonsteroidal anti-inflammatory agents _xCongresses. _954312 |
|
650 | 1 | 2 |
_aCyclooxygenase Inhibitors _vcongresses. _954313 |
650 | 2 | 2 |
_aAnti-Inflammatory Agents, Non-Steroidal _vcongresses. _954314 |
700 | 1 |
_aVane, John R. _954315 |
|
700 | 1 |
_aBotting, Jack H. _954316 |
|
711 | 2 |
_aWilliam Harvey Research Conference _d(1997 : _cCannes, France) _954317 |
|
906 |
_a7 _bcbc _ccopycat _d2 _encip _f19 _gy-gencatlg |
||
942 |
_2lcc _cBK |
||
999 |
_c24343 _d24343 |